Dose-Volume Histogram Analysis of External-Beam Irradiation Combined with IORT for Unresectable Pancreatic Cancer

1997 ◽  
pp. 177-180 ◽  
Author(s):  
M. Kokubo ◽  
Y. Nishimura ◽  
Y. Nagata ◽  
T. Mizowaki ◽  
M. Yamamoto ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Histogram Analysis ◽  
External Beam ◽  
Unresectable Pancreatic Cancer ◽  
Dose Volume Histogram ◽  
Beam Irradiation ◽  
External Beam Irradiation ◽  
Dose Volume

Intraoperative and external beam irradiation ± 5-FU for locally advanced pancreatic cancer

1987 ◽  
Vol 13 (3) ◽  
pp. 319-329 ◽  
Author(s):  
Leonard L. Gunderson ◽  
J.Kirk Martin ◽  
Larry K. Kvols ◽  
David M. Nagorney ◽  
Jennifer M. Fieck ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Locally Advanced ◽  
Advanced Pancreatic Cancer ◽  
Locally Advanced Pancreatic Cancer ◽  
External Beam ◽  
Beam Irradiation ◽  
External Beam Irradiation

Locally Advanced Pancreatic Cancer

2005 ◽  
Vol 23 (20) ◽  
pp. 4538-4544 ◽  
Author(s):  
Christopher G. Willett ◽  
Brian G. Czito ◽  
Johanna C. Bendell ◽  
David P. Ryan
Keyword(s):  
United States ◽  
Pancreatic Cancer ◽  
Advanced Disease ◽  
Locally Advanced ◽  
Advanced Pancreatic Cancer ◽  
The United States ◽  
External Beam ◽  
Targeted Agents ◽  
Beam Irradiation ◽  
External Beam Irradiation

Of the 32,180 patients diagnosed with pancreatic carcinoma in the United States this year, approximately 40% will present with locally advanced disease. Radiotherapeutic approaches are often employed because these patients have unresectable tumors by virtue of local invasion into the retroperitoneal vessels in the absence of clinically detectable metastases. These treatments include external-beam irradiation with and without fluorouracil-based chemotherapy, intraoperative irradiation, and, more recently, external-beam irradiation with new systemic targeted agents.

Sign in / Sign up

Export Citation Format

Share Document